Targeting RSK2 enhances the efficacy of IGF1R inhibitor against triple-negative breast cancer via antagonizing IGF1/IGF1R signaling mediated by GATA3-IGFBP5 pathway

Acta Pharmacologica Sinica 2026 Open access

Read full text

Authors: Tian-jiao Shan, Lei Li, Xiaoya Wan, LI Yi-zhi, Ting Jiang, Zong-lin Chen, Xiaohui Yu, Yan Cheng

DOI: 10.1038/s41401-025-01673-w

Cited by: 0

References: 43

Fields of Study & Subjects

Growth Hormone and Insulin-like Growth Factors Metastasis and carcinoma case studies Cancer Hypoxia and Metabolism

References 43